Skip to content
Discover Servier

Committed to the
fight against cancer

NEWSROOM

Our latest news

OUR THERAPEUTIC AREAS

Our solutions for patients

Cancer

A focused and innovative player developing targeted therapies to treat cancer

Cancer

Cardio metabolism

A strong commitment for over 60 years

Cardio metabolism

Neuroscience

A commitment to satisfy a major medical need

Neuroscience

Immuno-inflammation

Bring forward new treatment options

Immuno-inflammation
Our insights

Myelodysplastic syndromes (MDS): Getting the right diagnosis as early as possible

MDS affect the bone marrow, which then produces too few healthy blood cells. MDS are difficult to qualify owing to their complexity and can evolve into acute myeloid leukemia (AML) if not detected in time.

Our insights

Understanding acute myeloid leukemia

Acute myeloid leukemia (AML) is a rare disease which mainly affects the elderly. It is a cancer of the blood and bone marrow marked by rapid disease progression if untreated.

Our insights

All about acute lymphoblastic leukemia (ALL)

ALL is a bone marrow cancer that involves a specific type of white blood cells called lymphoblasts. This form of leukemia is a rare disease that affects children more frequently than adults, and more men than women.

Our insights

Cholangiocarcinoma, a rare tumor of the bile duct

Cholangiocarcinoma, a cancer of the bile ducts, is a rare and aggressive tumor. In most cases there is no identified causes, however it can often be linked to other risk factors such as inflammatory diseases, cirrhosis, or infections.

Our insights

Gastric cancer: a disease of the stomach

Gastric cancer is associated with several environmental and behavioral risk factors. Due to its general, nonspecific symptoms, this type of cancer is often detected too late, resulting in a poor prognosis.

Our insights

Colorectal cancer: screening too late

Colorectal cancer is a common disease. It is one of the most frequently diagnosed cancers in the world: it ranks third, behind lung cancer and liver cancer, and it affects almost as many women as men.

Our insights

Pancreatic cancer: Often diagnosed too late

Pancreatic cancer is one of the cancers with the poorest prognosis, with a 5-year survival rate of just 11%.

CAREERS

Join us!

Ready to express your talent for therapeutic progress?

Join us!